MSLN and mesothelioma: Although the MSLN protein is expressed at low levels in HMs, it is overexpressed in asbestos-exposed subjects (23, 24) and aberrantly expressed in several solid tumors, including gastric, lung, pancreatic, and ovarian cancers as well as in mesothelioma (25).